Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP710770.RAeOx0IftJZ1_xqaj9Ve3j1-7CpVZyJC2V1fmGzzGwLo4130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP710770.RAeOx0IftJZ1_xqaj9Ve3j1-7CpVZyJC2V1fmGzzGwLo4130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP710770.RAeOx0IftJZ1_xqaj9Ve3j1-7CpVZyJC2V1fmGzzGwLo4130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP710770.RAeOx0IftJZ1_xqaj9Ve3j1-7CpVZyJC2V1fmGzzGwLo4130_provenance.
- NP710770.RAeOx0IftJZ1_xqaj9Ve3j1-7CpVZyJC2V1fmGzzGwLo4130_assertion description "[These results suggest that targeted delivery of microRNA-124 and/or microRNA-137 to glioblastoma multiforme tumor cells may be therapeutically efficacious for the treatment of this disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP710770.RAeOx0IftJZ1_xqaj9Ve3j1-7CpVZyJC2V1fmGzzGwLo4130_provenance.
- NP710770.RAeOx0IftJZ1_xqaj9Ve3j1-7CpVZyJC2V1fmGzzGwLo4130_assertion evidence source_evidence_literature NP710770.RAeOx0IftJZ1_xqaj9Ve3j1-7CpVZyJC2V1fmGzzGwLo4130_provenance.
- NP710770.RAeOx0IftJZ1_xqaj9Ve3j1-7CpVZyJC2V1fmGzzGwLo4130_assertion SIO_000772 18577219 NP710770.RAeOx0IftJZ1_xqaj9Ve3j1-7CpVZyJC2V1fmGzzGwLo4130_provenance.
- NP710770.RAeOx0IftJZ1_xqaj9Ve3j1-7CpVZyJC2V1fmGzzGwLo4130_assertion wasDerivedFrom befree-20140225 NP710770.RAeOx0IftJZ1_xqaj9Ve3j1-7CpVZyJC2V1fmGzzGwLo4130_provenance.
- NP710770.RAeOx0IftJZ1_xqaj9Ve3j1-7CpVZyJC2V1fmGzzGwLo4130_assertion wasGeneratedBy ECO_0000203 NP710770.RAeOx0IftJZ1_xqaj9Ve3j1-7CpVZyJC2V1fmGzzGwLo4130_provenance.
- befree-20140225 importedOn "2014-02-25" NP710770.RAeOx0IftJZ1_xqaj9Ve3j1-7CpVZyJC2V1fmGzzGwLo4130_provenance.